Diagnostic Electrocardiograph Market to hit US$ 14.83 Billion by 2030 | Exclusive Report by Growth Plus Reports

News provided by

Sep 15, 2022, 09:20 ET

NEW YORK, Sept. 15, 2022 /PRNewswire/ -- According to the latest report published by growth plus reports, the global diagnostic electrocardiograph market is expected to clock US$ 14.83 billion by 2030 and to grow at a CAGR of 6.4% during the forecast period. Owing to the increasing geriatric population, technological advancement and collaboration between the companies are the key driving factors for the expansion of the market. This exclusive information is published by Growth Plus Reports in its report titled "diagnostic electrocardiograph Market – Global Outlook & Forecast 2022-2030".

Market Drivers

The aging population, which carries a higher risk of developing cardiovascular diseases, and rising public knowledge of the availability of non-invasive procedures are the main drivers of the global diagnostic electrocardiograph (ECG) market's expansion. Demand for reliable testing equipment, such as diagnostic electrocardiograph devices, has increased due to the rising prevalence of chronic cardiac disorders in western countries, which is caused by changes in lifestyle and dietary habits. Moreover, the expansion of healthcare infrastructure, favourable government reimbursement policies, and increased public and private sector investments in R&D activities are some other factors contributing to the growth of the global diagnostic electrocardiograph (ECG) market.

Download PDF Brochure of Diagnostic Electrocardiograph Market Size - COVID-19 Impact and Global Analysis with Strategic Developments at: https://growthplusreports.com/inquiry/request-sample/diagnostic-electrocardiograph-market/7804

Excerpts from 'Competitive Landscape'

Some of the prominent market player in the global diagnostic electrocardiograph market include:

Nihon Kohden Corporation
Asahi Kasei Corporation
Medtronic. Inc
Hill-Rom Holdings
General Electric Company (GE Healthcare)
Aerotel Medical Systems
Mortara Instrument Inc
AliveCor Inc
Welch Allyn
Compumed Inc.

Over the course of the projected period, it is also anticipated that the presence of competitors, mergers, acquisitions, and product releases would accelerate market expansion. For instance, in April 2022, the wireless, wearable Biotres cardiac monitoring device was introduced by Biotricity, a business that develops consumer healthcare and medical diagnostic technology. Pre-orders for the product were accepted from doctors, hospitals, and individuals for use from late February 2022.

Excerpts from 'By Product Segmentation'

Based on product, the global diagnostic electrocardiograph market has been segmented into:

Rest ECG System
Stress ECG System
Holter ECG System
Event Recorders
Others

The holter ECG system segment dominated the segment during forecast period. A new generation of portable and compact Holter ECGs, particularly in the home healthcare market, are pushing its increased acceptance on the diagnostic and monitoring front. Portable electrocardiograms include the Holter ECG system (ECG). It continually logs the heart's electrical activity for at least 24 hours. For instance, the newly developed ECG Holter is portable in size and inexpensive to be manufactured for mass production to aid patients with heart problems, according to the paper titled "A low-cost Holter monitor design integrated with external memory and Bluetooth connectivity" published in May 2020. A Bluetooth transmitter was also included in the design to send the data to the computer. The Holter ECG system is more prevalent in the projection period due to these recent developments and ease of accessibility.

Inquiry Before Buying: https://growthplusreports.com/inquiry/before-buying/diagnostic-electrocardiograph-market/7804

Excerpts from 'By Region Segmentation'

Based on the region, the global diagnostic electrocardiograph market has been segmented into:

North America
Europe
Asia Pacific
Rest of the World

The market for wireless ECG devices is dominated by North America, and forecasters anticipate no change in this trend over the projection period. The study region's market is expanding due to factors including the rising elderly population and the occurrence of cardiovascular illnesses. For instance, in 2022, heart disease and Stroke Statistics Update Fact Sheet, approximately every 40 seconds, a person in the United States is anticipated to have a myocardial infarction. As per the same source, Mortality attributable to subarachnoid hemorrhage was highest in Oceania, Andean Latin America, and Central Asia in 2020. Market expansion in North America will be fuelled by expanding R&D efforts, government initiatives, and product launches. For instance, the Centers for Disease Control and Prevention (CDC) and the Centres for Medicare & Medicaid Services are co-leading the national programme Million Hearts.

Table of Content

1. INTRODUCTION

Market Ecosystem
Timeline Under Consideration
Currency Used in the Report

2. RESEARCH METHODOLOGY

Research Approach
Data Collection Methodology
Data Sources

Secondary Sources
Primary Sources

Market Estimation Approach

Bottom Up
Top Down

Market Forecasting Model
Limitations and Assumptions

3. PREMIUM INSIGHTS

Current Market Trend (COVID-19 Perspective)
Key Players & Competitive Positioning (2021)

4. MARKET DYNAMICS

Drivers
Restraints/Challenges
Opportunities

5. GLOBAL DIAGNOSTIC ELECTROCARDIOGRAPH MARKET - ANALYSIS & FORECAST, BY PRODUCT

Rest ECG System
Stress ECG System
Holter ECG System
Event Recorders
Others

6. GLOBAL DIAGNOSTIC ELECTROCARDIOGRAPH MARKET - ANALYSIS & FORECAST, BY TECHNOLOGY

Portable ECG Systems
Wireless ECG Systems

7. GLOBAL DIAGNOSTIC ELECTROCARDIOGRAPH MARKET - ANALYSIS & FORECAST, BY LEAD TYPE

Single Lead ECG
3-6 Lead ECG
12 Lead ECG

8. GLOBAL DIAGNOSTIC ELECTROCARDIOGRAPH MARKET - ANALYSIS & FORECAST, BY END USER

Home-Based Users
Hospitals
Others

TOC Continued…

Directly Purchase Premium Copy of Diagnostic Electrocardiograph Market Growth Report (2022-2030) at: https://growthplusreports.com/checkout?_token=WoaXKmX57JswvzPoo1MRaPdybX5xB4FX6aFEPOHq&report_id=7804&license=Single

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.

Contact:

Manan Sethi
Director, Market Insights
Email: [email protected]
Phone no: +91 96545 76783
Web: https://growthplusreports.com/
Follow Us: LinkedIn | Twitter

Logo: https://mma.prnewswire.com/media/1671244/Growth_Plus_Reports_Logo.jpg

SOURCE Growth Plus Reports